Please login to the form below
medicines optimisation
This page shows the latest medicines optimisation news and features for those working in and with pharma, biotech and healthcare.
UK pharma to work with innovation network on NHS uptake
The UK pharma industry association the ABPI has announced a five-year deal with the AHSN Network aimed at encouraging a quicker, more consistent stream of medicines and other 'biomedical innovations' ... These areas include economic growth, digital
Latest news
-
Daily Brief: Theresa May and the diabetes sensor, Biosimilars hit Roche in Europe, Gilead CEO to step down
Strong launches for new medicines Ocrevus, Tecentriq and Alecensa, especially in Germany, partially offset the loss in Europe. ... The FreeStyle Libre has not been formally reviewed by NICE, but by England’s new network of Regional Medicines
-
NHS seeks 'solution creators' from within pharma
There has also been “a degree of convergence” among the people and bodies that work on assessing new medicines, he added, whether they be involved with NICE, the Cancer Drugs Fund ... However, a warning note about partnership working was sounded by
-
Pharma could make more of its real world evidence
But pharmaceutical companies do – and they are perfectly placed to help the NHS improve medicines optimisation. ... In reality, many pharma companies have adapted their operations to develop processes and strategies to collect RWE for their medicines.
-
Industry pays £310m to underwrite medicines bills
Industry agreed to the PPRS in order to improve the use of innovative medicines in the UK. ... We are working with the Department of Health, NHS England and government to ensure action in key areas such as changes to NICE's decision making framework and
-
Patients should have a say in their medication, claims NICE
Paul Chrisp, programme director for the medicines and prescribing centre at NICE, said: “The NICE guideline on medicines optimisation sets out what needs to be done by all health and social ... Medicines optimisation is not a new concept. “This
More from news
Approximately 10 fully matching, plus 16 partially matching documents found.
Latest Intelligence
-
Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?
In recent years, biosimilars (highly similar copies of biologic medicines) have taken large shares of many markets. ... Considerable effort was directed towards medicines optimisation and building an evidence base for the wider use of NOACs in
-
How AbbVie Care is putting patients at the centre
Industry must assume a responsibility to move beyond just the manufacture of medicines. ... Create a reliable supply chain ensuring that patients get the right medicine at the right time, supporting medicines optimisation.
-
It's time to get diabetes right
All with negative implications for patients - but to date focusing on specialist medicines. ... It is clear that the medicines optimisation agenda is of more importance now than ever.
-
Communicating value
The global recession has changed the way the industry needs to market its medicines. ... In England the NHS-driven Medicines Optimisation programme will this year engage local payers and providers on the ability of good medicines usage to improve patient
More from intelligence
Approximately 0 fully matching, plus 4 partially matching documents found.
Latest appointments
-
ABPI names NHS partnership manager
In his new role, he will manage the four ABPI regional partnership managers and lead ABPI activities in academic health science networks and medicines optimisation. ... ensure appropriate medicines and technologies are available to all eligible
More from appointments
Approximately 0 fully matching, plus 1 partially matching documents found.
Latest from PMHub
-
NHS medicines optimisation milestone
Regional Medicines Optimisation Committees(RMOCs), which were launched last year, have been playing a pivotal role in working with NHS commissioners and providers on best value biologics and helping them to ... by 2020/21 if the NHS embraces the use of
-
Sir Bruce Keogh is appointed chair of judges for HSJ Awards
The eight new awards include acute or specialist services redesign, patient digital participation, creating a supportive staff culture and optimisation of medicines management.
-
Unique forum will unite NHS and industry to drive innovation
The event aims to help industry develop stronger relationships with leaders from NHS England, Regional Medicines Optimisation Committees (RMOCs), Sustainability and Transformation Partnerships (STPs) and Integrated Care Systems (ICSs), and influence
-
How will the NHS’s new medicines savings drive affect pharma?
The CCGs will be monitored by four Regional Medicines Optimisation Committees(RMOCs) which were launched recently to avoid duplication when evaluating medicines, particularly those which are not evaluated by NICE. . ... Thanks to powerful data analytics
More from PMHub
Approximately 0 fully matching, plus 4 partially matching documents found.
Featured jobs
-
Senior Account Manager
-
Competitive Salary Offered
- CALLING ALL SENIOR HEALTHCARE PR FREELANCERS!!!!! ACCOUNT DIRECT...
-
EXCELLENT DAY RATES AVAILABLE
-
Systematic Reviewer - Oxford
-
Negotiable
- Business Development Director – Health Education
-
excellent commission
- Manager - Immunology, Therapeutic Area Communications & Publ...
-
Competitive Salary Offered
-
Account Manager
-
Negotiable
-
Medical Writer
-
Bonus Scheme, PTO &Private Healthcare
- Account Manager- Healthcare Advertising
-
Negotiable
-
Associate Medical Director
-
Excellent PTO, bonus and 401k package
-
Business Director
-
Competitive Salary Offered
-
Medical (Scientific) Director
-
£120, 000 benefits
- Account Manager / Senior Account Manager
-
35, 000-40, 000
-
Experienced Medical Writers
-
Competitive Salary and Benefits
- Account Executive/ Senior Account Executive
-
competitive Salary Offfered
-
Medical Writer
-
Salary TBC
-
Account Director
-
Competitive Salary Offered
-
Associate Director
-
£75, 000-90, 000
- Principal Health Economist - North-West
-
Negotiable
-
Account Manager / Account Director
-
Competative
Subscribe to our email news alerts
PMHub
Fishawack Group of Companies
The Fishawack Group of Companies is one of the largest independent medical communications and medical marketing specialists, with teams in...
Latest intelligence
- AstraZeneca’s oncology renaissance
- Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
- Navigating the antibiotic resistance crisis
- Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
- Combined immunotherapies – potential and pitfalls
- ‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Quick links
Infographics
